Glenmark Pharma shares gained 2.08% to trade at Rs 2,084.80 at 10:45 am. This increase reflects a positive movement in the stock's price compared to its previous close.
Financial Snapshot:
Here's a look at Glenmark Pharma's recent financial performance based on consolidated figures:
Income Statement (Quarterly - Crore)
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|
| Sales | Rs 3,264 | Rs 3,256 | Rs 3,387 | Rs 3,433 | Rs 3,244 |
| Other Income | Rs 26 | Rs 11 | Rs 31 | Rs 39 | Rs 31 |
| Total Income | Rs 3,290 | Rs 3,267 | Rs 3,418 | Rs 3,473 | Rs 3,275 |
| Total Expenditure | Rs 3,137 | Rs 3,193 | Rs 2,910 | Rs 2,952 | Rs 2,773 |
| EBIT | Rs 153 | Rs 74 | Rs 508 | Rs 521 | Rs 501 |
| Interest | Rs 58 | Rs 66 | Rs 52 | Rs 48 | Rs 39 |
| Tax | Rs 48 | Rs 3 | Rs 108 | Rs 118 | Rs 122 |
| Net Profit | Rs 46 | Rs 4 | Rs 348 | Rs 354 | Rs 340 |
Income Statement (Yearly - Crore)
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | Rs 13,321 | Rs 11,813 | Rs 12,990 | Rs 12,304 | Rs 10,943 |
| Other Income | Rs 113 | Rs 839 | Rs 316 | Rs 166 | Rs 50 |
| Total Income | Rs 13,435 | Rs 12,653 | Rs 13,306 | Rs 12,471 | Rs 10,994 |
| Total Expenditure | Rs 11,829 | Rs 12,100 | Rs 12,088 | Rs 10,732 | Rs 9,258 |
| EBIT | Rs 1,606 | Rs 552 | Rs 1,218 | Rs 1,739 | Rs 1,735 |
| Interest | Rs 207 | Rs 515 | Rs 349 | Rs 298 | Rs 353 |
| Tax | Rs 352 | Rs 1,867 | Rs 491 | Rs 447 | Rs 412 |
| Net Profit | Rs 1,047 | Rs -1,830 | Rs 377 | Rs 993 | Rs 970 |
Cash Flow (Yearly - Crore)
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Operating Activities | Rs -827 | Rs -265 | Rs 625 | Rs 1,108 | Rs 1,131 |
| Investing Activities | Rs 2 | Rs 4,560 | Rs -528 | Rs -333 | Rs -675 |
| Financing Activities | Rs 787 | Rs -3,906 | Rs -77 | Rs -520 | Rs -441 |
| Others | Rs 55 | Rs -174 | Rs 13 | Rs 17 | Rs 13 |
| Net Cash Flow | Rs 17 | Rs 215 | Rs 32 | Rs 272 | Rs 27 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Share Capital | Rs 28 | Rs 28 | Rs 28 | Rs 28 | Rs 28 |
| Reserves & Surplus | Rs 8,821 | Rs 7,801 | Rs 9,445 | Rs 9,058 | Rs 7,036 |
| Current Liabilities | Rs 5,967 | Rs 5,818 | Rs 5,045 | Rs 4,689 | Rs 4,201 |
| Other Liabilities | Rs 1,233 | Rs 710 | Rs 4,852 | Rs 3,307 | Rs 4,337 |
| Total Liabilities | Rs 16,049 | Rs 14,358 | Rs 19,371 | Rs 17,083 | Rs 15,603 |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Fixed Assets | Rs 5,251 | Rs 4,804 | Rs 7,380 | Rs 6,837 | Rs 6,452 |
| Current Assets | Rs 9,295 | Rs 7,428 | Rs 9,873 | Rs 8,282 | Rs 7,359 |
| Other Assets | Rs 1,502 | Rs 2,125 | Rs 2,117 | Rs 1,963 | Rs 1,791 |
| Total Assets | Rs 16,049 | Rs 14,358 | Rs 19,371 | Rs 17,083 | Rs 15,603 |
| Ratio | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 37.11 | -53.22 | 10.53 | 33.37 | 34.38 |
| Diluted EPS (Rs.) | 37.11 | -53.22 | 10.53 | 33.37 | 34.38 |
| Book Value/Share (Rs.) | 313.60 | 278.09 | 348.70 | 334.48 | 250.36 |
| Dividend/Share (Rs.) | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Face Value | 1 | 1 | 1 | 1 | 1 |
| Gross Profit Margin (%) | 18.50 | 17.22 | 19.97 | 20.21 | 19.50 |
| Operating Margin (%) | 14.85 | 12.30 | 15.27 | 16.25 | 15.45 |
| Net Profit Margin (%) | 7.86 | -12.13 | 2.90 | 8.07 | 8.86 |
| Return on Equity (%) | 11.83 | -19.13 | 3.13 | 10.36 | 13.73 |
| ROCE (%) | 19.62 | 17.01 | 13.84 | 16.13 | 14.83 |
| Return On Assets (%) | 6.52 | -10.45 | 1.53 | 5.51 | 6.21 |
| Current Ratio (X) | 1.56 | 1.28 | 1.96 | 1.77 | 1.75 |
| Quick Ratio (X) | 1.05 | 0.84 | 1.37 | 1.23 | 1.21 |
| Debt to Equity (x) | 0.25 | 0.13 | 0.46 | 0.40 | 0.66 |
| Interest Coverage (X) | 11.90 | 3.94 | 7.42 | 8.34 | 6.05 |
| Asset Turnover Ratio (%) | 0.88 | 0.70 | 0.71 | 0.42 | 0.43 |
| Inventory Turnover Ratio (X) | 1.08 | 1.15 | 1.31 | 1.85 | 1.85 |
| 3 Yr CAGR Sales (%) | 4.05 | 3.90 | 10.49 | 11.68 | 9.82 |
| 3 Yr CAGR Net Profit (%) | 2.66 | 37.38 | -30.26 | 3.64 | 9.85 |
| P/E (x) | 41.53 | -18.01 | 44.13 | 13.25 | 13.52 |
| P/B (x) | 4.91 | 3.44 | 1.38 | 1.37 | 1.86 |
| EV/EBITDA (x) | 17.83 | 12.95 | 6.31 | 6.07 | 7.80 |
| P/S (x) | 3.26 | 2.29 | 1.01 | 1.01 | 1.20 |
Glenmark Pharmaceuticals announced a final dividend of Rs 2.50 per share (250%) with an effective date of September 15, 2025. The company had earlier announced on September 15, 2025, a Business Transfer Agreement for the transfer of its Consumer Care Business to Glenmark Consumer Care Limited, a wholly-owned subsidiary, expected to be completed on or before December 31, 2025. The company also had a stock split on 10 Sep, 2007 where old FV was 2 and new FV was 1. Glenmark Pharmaceuticals had also announced a bonus issue with a bonus ratio of 1:1, exbonus date being 04 Mar, 2005.
The stock is a constituent of the Nifty Midcap 150 index. Moneycontrol analysis, performed on September 17, 2025, indicates a bullish sentiment for the stock.
This increase reflects a positive movement in the stock's price compared to its previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
